DD262230A5 - Verfahren zur herstellung neuer derivate von 4,5-dihydro-oxazolen - Google Patents

Verfahren zur herstellung neuer derivate von 4,5-dihydro-oxazolen Download PDF

Info

Publication number
DD262230A5
DD262230A5 DD87306817A DD30681787A DD262230A5 DD 262230 A5 DD262230 A5 DD 262230A5 DD 87306817 A DD87306817 A DD 87306817A DD 30681787 A DD30681787 A DD 30681787A DD 262230 A5 DD262230 A5 DD 262230A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
dihydro
general formula
mmol
filtered
Prior art date
Application number
DD87306817A
Other languages
German (de)
English (en)
Inventor
Dieter Binder
Franz Rovenszky
Hubert P Ferber
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD262230A5 publication Critical patent/DD262230A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
DD87306817A 1986-09-10 1987-09-09 Verfahren zur herstellung neuer derivate von 4,5-dihydro-oxazolen DD262230A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT243786 1986-09-10

Publications (1)

Publication Number Publication Date
DD262230A5 true DD262230A5 (de) 1988-11-23

Family

ID=3534337

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87306817A DD262230A5 (de) 1986-09-10 1987-09-09 Verfahren zur herstellung neuer derivate von 4,5-dihydro-oxazolen

Country Status (21)

Country Link
US (1) US4818760A (fr)
EP (1) EP0261478B1 (fr)
JP (1) JPS6377878A (fr)
KR (1) KR880003941A (fr)
AT (1) ATE62908T1 (fr)
AU (1) AU596869B2 (fr)
CA (1) CA1256109A (fr)
CS (1) CS268191B2 (fr)
DD (1) DD262230A5 (fr)
DE (1) DE3769563D1 (fr)
DK (1) DK165322C (fr)
ES (1) ES2028838T3 (fr)
FI (1) FI89267C (fr)
GR (1) GR3001842T3 (fr)
HU (1) HU198059B (fr)
MY (1) MY102003A (fr)
NO (1) NO165195C (fr)
NZ (1) NZ221723A (fr)
SG (1) SG39892G (fr)
SU (1) SU1574177A3 (fr)
ZA (1) ZA876740B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983263A1 (fr) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2000074654A1 (fr) 1999-06-07 2000-12-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparation et forme galenique comprenant un compose actif acido-labile
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
AU2005239838B2 (en) * 2004-05-07 2011-08-11 Takeda Gmbh Pharmaceutical dosage form comprising pellets as well as its manufacturing process
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (fr) * 2006-04-03 2014-03-11 Isa Odidi Dispositif d'administration a liberation commandee comprenant un enrobage organosol
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
EP0234485B1 (fr) * 1986-02-20 1992-04-01 Hoechst Aktiengesellschaft Dérivés substitués du thiénoimidazole, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur application comme inhibiteurs de la sécrétion du suc gastrique

Also Published As

Publication number Publication date
JPS6377878A (ja) 1988-04-08
EP0261478B1 (fr) 1991-04-24
FI89267B (fi) 1993-05-31
DK165322C (da) 1993-03-29
SU1574177A3 (ru) 1990-06-23
CA1256109A (fr) 1989-06-20
NO165195C (no) 1991-01-09
HUT47288A (en) 1989-02-28
HU198059B (en) 1989-07-28
ES2028838T3 (es) 1992-07-16
MY102003A (en) 1992-02-29
NZ221723A (en) 1989-11-28
NO873722D0 (no) 1987-09-07
GR3001842T3 (en) 1992-11-23
DK469687A (da) 1988-03-11
FI873892A0 (fi) 1987-09-09
NO873722L (no) 1988-03-11
ZA876740B (en) 1988-03-14
CS268191B2 (en) 1990-03-14
KR880003941A (ko) 1988-05-31
CS649787A2 (en) 1989-05-12
DK165322B (da) 1992-11-09
AU7817087A (en) 1988-03-17
EP0261478A1 (fr) 1988-03-30
US4818760A (en) 1989-04-04
FI89267C (fi) 1993-09-10
ATE62908T1 (de) 1991-05-15
FI873892A (fi) 1988-03-11
SG39892G (en) 1992-10-02
AU596869B2 (en) 1990-05-17
NO165195B (no) 1990-10-01
DK469687D0 (da) 1987-09-09
DE3769563D1 (de) 1991-05-29

Similar Documents

Publication Publication Date Title
EP0001279B1 (fr) Dérivés de l'imidazole leur procédé de préparation et leurs compositions pharmaceutiques
DE3752201T2 (de) Pyridin-Derivate, deren pharmazeutische Zusammenstellungen, deren Anwendung für die Herstellung von Arzneimitteln mit therapeutischem oder vorbeugendem Wert und Verfahren zu deren Herstellung
EP0134400B1 (fr) Pyridylméthylthio-(ou sulfinyl-)benzimidazoles substitués par fluoroalkoxy à activité sécrétolytique
EP0080602A1 (fr) Benzimidazoles substitués, procédé de leur préparation, leur application et les médicaments les contenant
DE3433924A1 (de) 6-fluoro-1,4-dihydro-4-oxo-7-substituierte piperazinyl-chinolin-3-carbonsaeure-derivate und verfahren zu ihrer herstellung
EP0127763B1 (fr) Ethers tricycliques, procédé pour leur préparation, leur utilisation et médicaments les contenant
EP0263352A1 (fr) Imidazo-benzoxazinones, leur préparation et médicaments contenant ces composés
EP0261478B1 (fr) Dérivés de 4,5 dihydro-oxazoles, procédé de leur préparation et leur application
DE3533331A1 (de) Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3782621T2 (de) Imidazol-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, welche diese enthalten, verwendung dieser zur herstellung therapeutisch wirksamer arzneimittel und zwischenprodukte, welche beim herstellungsverfahren entstehen.
DE19513048C2 (de) Neue 5-Pyrrolyl-6-halogen-2-pyridylmethylsulfinylbenzimidazol-Derivate
DE2602643A1 (de) 1,2-benzisothiazolinone-3, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0201094A2 (fr) Dérivés de thiéno[2,3-d] imidazole et leur procédé de préparation
EP0213474B1 (fr) Toluidines substituées, leur procédé de préparation, compositions pharmaceutiques les contenant et leur application comme agent inhibiteur de sécrétion gastrique
DE3415971A1 (de) Acylierte benzimidazole, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel
EP0211157B1 (fr) Derivés d'isoxazole, procédé de préparation et préparations pharmaceutiques les contenant
EP0138034B1 (fr) Pyrido[1,2-c]imidazo[1,2-a]benzimidazoles substitués, procédé pour leur préparation, leur application et compositions pharmaceutiques à base de ces composés
WO1989011479A1 (fr) Nouveaux composes fluores d'alkoxyde
EP0240026A1 (fr) Benzoglyoxalines substituées hétérocycliquement, procédé pour leur préparation et médicaments contenant ces composés
DE60013607T2 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
CZ278281B6 (en) ENOL ETHER OF 1,1-DIOXIDE OF 6-CHLORO-4-HYDROXY-2-METHYL-N- (2-PYRIDYL-2H-THIENO(2,3-c)-1,2-THIAZINECARBOXYLIC ACID AMIDE, PROCESS OF ITS PREPARATION AND ITS USE
EP0207483A2 (fr) Benzimidazoles, procédé pour leur préparation, médicaments les contenant et intermédiaires
DE2459955A1 (de) Neue vinylderivate mit antibakterieller aktivitaet sowie verfahren zu deren herstellung
AT400568B (de) Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
EP0149131A2 (fr) Imidazo (4,5-c) pyridinones, leur préparation et médicaments les contenant

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee